Zárraga S - Search Results

1

Conversion to everolimus in kidney transplant recipients with decreased renal function.

Inza A, Balda S, Alvarez E, Zárraga S, Gaínza FJ, Lampreabe I. Inza A, et al. Among authors: zarraga s. Transplant Proc. 2009 Jul-Aug;41(6):2134-6. doi: 10.1016/j.transproceed.2009.05.013. Transplant Proc. 2009. PMID: 19715854

2

Accidental substitution of acidic concentrate for acetate in dialysis fluid concentrate: a cause of severe metabolic acidosis.

Gainza FJ, Zárraga S, Minguela I, Lampreabe I. Gainza FJ, et al. Among authors: zarraga s. Nephron. 1995;69(4):480-2. doi: 10.1159/000188525. Nephron. 1995. PMID: 7777118 Free article. No abstract available.

3

Assessment of distal tubular function in Gitelman's syndrome.

Zarraga S, Gainza FJ, Vallo A. Zarraga S, et al. Pediatr Nephrol. 1994 Apr;8(2):262. doi: 10.1007/BF00865498. Pediatr Nephrol. 1994. PMID: 8018511 No abstract available.

4

[Assessment of integrated replacement therapy in patients with terminal renal insufficiency: selection vs election].

Lampreabe I, Muñiz ML, Zárraga S, Amenábar JJ, Erauzkin GG, Gómez-Ullate P, Gaínza FJ. Lampreabe I, et al. Among authors: zarraga s. Nefrologia. 2001;21 Suppl 5:4-13. Nefrologia. 2001. PMID: 11881412 Free article. Review. Spanish. No abstract available.

5

[Presentation of cancers in recipients of a solid-organ transplant].

Lampreabe I, Gómez-Ullate P, Amenábar JJ, Zárraga S, Gaínza FJ, Urbizu JM. Lampreabe I, et al. Among authors: zarraga s. Nefrologia. 2001;21(6):528-37. Nefrologia. 2001. PMID: 11881422 Free article. Review. Spanish. No abstract available.

6

Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience.

Urbizu JM, Amenabar JJ, Gomez-Ullate P, Zarraga S, Lampreabe I. Urbizu JM, et al. Among authors: zarraga s. Transplant Proc. 2002 Feb;34(1):87-8. doi: 10.1016/s0041-1345(01)02679-3. Transplant Proc. 2002. PMID: 11959197 No abstract available.

7

Long-term efficacy of hyperuricaemia treatment in renal transplant patients.

Perez-Ruiz F, Gomez-Ullate P, Amenabar JJ, Zarraga S, Calabozo M, Herrero-Beites AM, Nolla JM. Perez-Ruiz F, et al. Among authors: zarraga s. Nephrol Dial Transplant. 2003 Mar;18(3):603-6. doi: 10.1093/ndt/18.3.603. Nephrol Dial Transplant. 2003. PMID: 12584286

8

Safety and efficacy of tacrolimus rescue therapy in 55 kidney transplant patients treated with cyclosporine.

Urbizu JM, Zárraga S, Gómez-Ullate P, Amenábar JJ, Gaínza FI, Lampreabe I, Virto J, Orbe J. Urbizu JM, et al. Among authors: zarraga s. Transplant Proc. 2003 Aug;35(5):1704-5. doi: 10.1016/s0041-1345(03)00610-9. Transplant Proc. 2003. PMID: 12962765

9

[Statistic analysis of "de novo" cancer incidence in renal transplant patients: a new study methodology].

Virto J, Orbe J, Lampreabe I, Zárraga S, Urbizu JM, Gaínza FJ. Virto J, et al. Among authors: zarraga s. Nefrologia. 2003 Sep-Oct;23(5):395-8. Nefrologia. 2003. PMID: 14658165 Free article. Review. Spanish. No abstract available.

10

Use of the new proliferation signal inhibitor everolimus in renal transplant patients in Spain: preliminary results of the EVERODATA registry.

Ruiz JC, Sánchez A, Rengel M, Beneyto I, Plaza JJ, Zárraga S, Errasti P, Andrés A, Morales JM, Torregrosa JV, Alarcón A, Morey A, Romero R, Fernández A, Díaz JM, Cantarell C; EVERODATA Group. Ruiz JC, et al. Among authors: zarraga s. Transplant Proc. 2007 Sep;39(7):2157-9. doi: 10.1016/j.transproceed.2007.07.071. Transplant Proc. 2007. PMID: 17889123

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page